Cite

HARVARD Citation

    Labbé, C. et al. (2017). Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC). Lung cancer. pp. 23-29. [Online]. 
  
Back to record